Literature DB >> 680037

A comparison of topical cannabinoids on intraocular pressure.

K Green, H Wynn, K A Bowman.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 680037     DOI： 10.1016/0014-4835(78)90092-1

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  6 in total

Review 1.  Cannabinoids in clinical practice.

Authors:  E M Williamson; F J Evans
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

2.  Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.

Authors:  Matt H Oltmanns; Sandeep S Samudre; Ivan G Castillo; Alireza Hosseini; Aron H Lichtman; Robert C Allen; Frank A Lattanzio; Patricia B Williams
Journal:  J Ocul Pharmacol Ther       Date:  2008-02       Impact factor: 2.671

Review 3.  Advances in the use of prodrugs for drug delivery to the eye.

Authors:  Pranjal Taskar; Akshaya Tatke; Soumyajit Majumdar
Journal:  Expert Opin Drug Deliv       Date:  2016-07-21       Impact factor: 6.648

4.  Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.

Authors:  Sally Miller; Laura Daily; Emma Leishman; Heather Bradshaw; Alex Straiker
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-12-03       Impact factor: 4.799

5.  The Effects of Cannabidiol on Aqueous Humor Outflow and Trabecular Meshwork Cell Signaling.

Authors:  Alyssa S Aebersold; Zhao-Hui Song
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

6.  Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent.

Authors:  Alyssa Aebersold; Max Duff; Lucy Sloan; Zhao-Hui Song
Journal:  Cell Physiol Biochem       Date:  2021-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.